How much is a payer willing to pay for a QALY gain? – By Prof. Dr. Lieven Annemans

In this 2-min video, Prof. Dr. Lieven Annemans explains how payers decide on reimbursing a new treatment based on the number of QALYs gained, and how that differs between countries. It’s a great video with animation!

Attend Lieven’s popular 2-day CELforPharma course Health Economics for Non-Health-Economists  if you want to be able to understand and discuss the health economic evaluation studies of your brands (or of its competitors), and be able to have meaningful HECON conversations with external and internal stakeholders.

If your budget or agenda doesn’t allow you to join us in Brussels for 2 immersive days of learning, our Self-Study Programme Basics of Health Economics allows you to learn from Prof. Dr. Lieven Annemans at your own pace and from a location of your choice, during a 4 week time frame.